Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
CNS Pharmaceuticals, Inc.Listing on record | Sell | $6.5K | SEC | ||
CNS Pharmaceuticals, Inc.Listing on record | Sell | $6.2K | SEC | ||
CNS Pharmaceuticals, Inc.Listing on record | Sell | $5.5K | SEC | ||
CNS Pharmaceuticals, Inc.Listing on record | Sell | $6.5K | SEC | ||
CNS Pharmaceuticals, Inc.Listing on record | Sell | $6.8K | SEC | ||
CNS Pharmaceuticals, Inc.Listing on record | Sell | $13.6K | SEC | ||
CNS Pharmaceuticals, Inc.Listing on record | Sell | $13.2K | SEC | ||
CNS Pharmaceuticals, Inc.Listing on record | Sell | $10.4K | SEC | ||
CNS Pharmaceuticals, Inc.Listing on record | Sell | $6.1K | SEC | ||
CNS Pharmaceuticals, Inc.Listing on record | Sell | $6.8K | SEC | ||
CNS Pharmaceuticals, Inc.Listing on record | Sell | $5.6K | SEC | ||
CNS Pharmaceuticals, Inc.Listing on record | Sell | $13.5K | SEC | ||
CNS Pharmaceuticals, Inc.Listing on record | Sell | $5.4K | SEC | ||
CNS Pharmaceuticals, Inc.Listing on record | Sell | $5.4K | SEC | ||
CNS Pharmaceuticals, Inc.Listing on record | Sell | $10.8K | SEC | ||
CNS Pharmaceuticals, Inc.Listing on record | Sell | $5.4K | SEC | ||
CNS Pharmaceuticals, Inc.Listing on record | Sell | $5.5K | SEC | ||
CNS Pharmaceuticals, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Moleculin Biotech, Inc.Listing on record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Moleculin Biotech, Inc.Listing on record | Sell | $170K | SEC |